SF 11

NPY Y2 receptor antagonist CAS# 443292-81-7

SF 11

Catalog No. BCC7805----Order now to get a substantial discount!

Product Name & Size Price Stock
SF 11: 5mg $115 In Stock
SF 11: 10mg Please Inquire In Stock
SF 11: 20mg Please Inquire Please Inquire
SF 11: 50mg Please Inquire Please Inquire
SF 11: 100mg Please Inquire Please Inquire
SF 11: 200mg Please Inquire Please Inquire
SF 11: 500mg Please Inquire Please Inquire
SF 11: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of SF 11

Number of papers citing our products

Chemical structure

SF 11

3D structure

Chemical Properties of SF 11

Cas No. 443292-81-7 SDF Download SDF
PubChem ID 2936384 Appearance Powder
Formula C27H30N2O2S M.Wt 446.6
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble to 100 mM in DMSO and to 50 mM in ethanol
Chemical Name N-(4-ethoxyphenyl)-4-[hydroxy(diphenyl)methyl]piperidine-1-carbothioamide
SMILES CCOC1=CC=C(C=C1)NC(=S)N2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O
Standard InChIKey PMEQBGAGFZDWQX-UHFFFAOYSA-N
Standard InChI InChI=1S/C27H30N2O2S/c1-2-31-25-15-13-24(14-16-25)28-26(32)29-19-17-23(18-20-29)27(30,21-9-5-3-6-10-21)22-11-7-4-8-12-22/h3-16,23,30H,2,17-20H2,1H3,(H,28,32)
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of SF 11

DescriptionNPY Y2 antagonist (IC50 = 199 nM). Displays no affinity for Y1 receptor at concentrations up to 35 μM. Causes significant lethality in mice. Brain penetrant.

SF 11 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

SF 11 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of SF 11

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.2391 mL 11.1957 mL 22.3914 mL 44.7828 mL 55.9785 mL
5 mM 0.4478 mL 2.2391 mL 4.4783 mL 8.9566 mL 11.1957 mL
10 mM 0.2239 mL 1.1196 mL 2.2391 mL 4.4783 mL 5.5979 mL
50 mM 0.0448 mL 0.2239 mL 0.4478 mL 0.8957 mL 1.1196 mL
100 mM 0.0224 mL 0.112 mL 0.2239 mL 0.4478 mL 0.5598 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
  • Isopedicin

    Catalog No.:BCN4633
    CAS No.:4431-42-9
  • Ligustilide

    Catalog No.:BCN1031
    CAS No.:4431-01-0
  • Metronidazole

    Catalog No.:BCC9046
    CAS No.:443-48-1
  • Tabersonine

    Catalog No.:BCN5496
    CAS No.:4429-63-4
  • Methyl isodrimeninol

    Catalog No.:BCN5495
    CAS No.:442851-27-6
  • Anguizole

    Catalog No.:BCC1365
    CAS No.:442666-98-0
  • JW 67

    Catalog No.:BCC6251
    CAS No.:442644-28-2
  • CK 666

    Catalog No.:BCC6088
    CAS No.:442633-00-3
  • CK-636

    Catalog No.:BCC5107
    CAS No.:442632-72-6
  • Aspertine C

    Catalog No.:BCN2153
    CAS No.:442155-62-6
  • Clemizole

    Catalog No.:BCC1485
    CAS No.:442-52-4
  • Harmine

    Catalog No.:BCN5494
    CAS No.:442-51-3
New Products
 

References on SF 11

[The Health-Related Quality of Life as Measured with the SF-12v1 in Elderly People Living in Luebeck 2010/11 in Comparison with the German Norm Data in 1994].[Pubmed:25350388]

Gesundheitswesen. 2016 Jan;78(1):49-55.

BACKGROUND: Health-related quality of life (HRQL) is deemed to be a meaningful endpoint when evaluating therapy and prevention interventions. For comparison purposes not only patient data but also representative population samples can serve as reference data. We aim to describe differences between the Luebeck population sample (LBS, year 2010/11) and the German norm population from 1994. Moreover, the influence of diabetes mellitus and hypertension on HRQL is analysed. METHODS: The LBS is a representative sample of 10 000 elderly people living in Luebeck aged 51-80 years, an age group susceptible to chronic diseases. Not only the SF-12v1, but also the item "actual health status in comparison to the last year" of the SF-36 and a list of comorbidities have been applied. Descriptive statistics are given for age, sex and disease groups. A comparison with data from the DNSP going back to 1994 is made using unstandardised data as well as age- and gender-standardised data. RESULTS: 5 835 individuals (response rate 60%) did participate in the survey (48% male, mean age 63.9 years, SD 7.7). PSC and MSC could be computed for 80% of them. Unstandardised values are 44.3+/-10.8 for the PSC and 50.4+/-10.3 for the MSC. Applying standardisation by age and gender, PSC values were comparable between the LBS and DNSP (except for the age group 51-60 years). MSC values were significantly lower in the LBS. The "general health Status" does not significantly differ whereas the "actual health status in comparison to the last year" is significantly lower in the LBS than in the DNSP (p<0.001). CONCLUSIONS: The LBS comprises more individuals than older studies in an age group relevant for chronic diseases. RESULTS hint to a comparable physical HRQL but a worse mental HRQL in the current data set. It remains unclear why persons between 51 and 60 years assess their physical HRQL worse than in the DNSP. A further open question is why the "actual health status in comparison to the last year" is assessed more negatively. Changed context conditions in working and social life may have an influence.

Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening.[Pubmed:19837904]

Mol Pharmacol. 2010 Jan;77(1):46-57.

The role of neuropeptide Y Y2 receptor (Y2R) in human diseases such as obesity, mood disorders, and alcoholism could be better resolved by the use of small-molecule chemical probes that are substantially different from the currently available Y2R antagonist, N-[(1S)-4-[(aminoiminomethyl)amino]-1-[[[2-(3,5-dioxo-1,2-diphenyl-1,2,4-triazoli din-4-yl)ethyl]amino]carbonyl]butyl]-1-[2-[4-(6,11-dihydro-6-oxo-5H-dibenz[b,e]az epin-11-yl)-1-piperazinyl]-2-oxoethyl]-cyclopentaneacetamide) (BIIE0246). Presented here are five potent, selective, and publicly available Y2R antagonists identified by a high-throughput screening approach. These compounds belong to four chemical scaffolds that are structurally distinct from the peptidomimetic BIIE0246. In functional assays, IC(50) values between 199 and 4400 nM against the Y2R were measured, with no appreciable activity against the related NPY-Y1 receptor (Y1R). Compounds also displaced radiolabeled peptide YY from the Y2R with high affinity (K(i) values between 1.55 and 60 nM) while not displacing the same ligand from the Y1R. In contrast to BIIE0246, Schild analysis with NPY suggests that two of the five compounds behave as competitive antagonists. Profiling against a panel of 40 receptors, ion channels, and transporters found in the central nervous system showed that the five Y2R antagonists demonstrate greater selectivity than BIIE0246. Furthermore, the ability of these antagonists to penetrate the blood-brain barrier makes them better suited for pharmacological studies of Y2R function in both the brain and periphery.

Keywords:

SF 11,443292-81-7,Natural Products,NPY Receptors, buy SF 11 , SF 11 supplier , purchase SF 11 , SF 11 cost , SF 11 manufacturer , order SF 11 , high purity SF 11

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: